Schneider Joel Solomon Zev 4
4 · Solid Biosciences Inc. · Filed Jan 29, 2021
Insider Transaction Report
Form 4
Schneider Joel Solomon Zev
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2021-01-27+11,500→ 295,615 total - Sale
Common Stock
[F2]2021-01-28$6.14/sh−3,443$21,145→ 292,172 total - Exercise/Conversion
Restricted Stock Units
[F1][F3]2021-01-27−11,500→ 0 total→ Common Stock (11,500 underlying)
Footnotes (3)
- [F1]Restricted Stock units convert into common stock on a one-for-one basis.
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.
- [F3]On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vested six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date
Signature
/s/ by Ilan Ganot as attorney-in-fact for Joel Solomon Zev Schneider|2020-01-29